Last Price Today's Change   Day's Range   Trading Volume
13.18   +0.10 (0.76%)  13.08 - 13.18  41,900
Analyze this stock with MQ Trader system

Dividend, Bonus, Split & Consolidation

Hints :
[1] Click the View Entitlement icon table to view the Entitlement detail page.

Click here to modify the Visible Columns.

Ann. Date Ex Date Payment Date Type Subject Amount View
18-Feb-2000 10-Mar-2000 17-Mar-2000 BONUS_ISSUE Bonus Issue 1 : 3 Dividend Detail
08-Aug-2002 23-Aug-2002 27-Aug-2002 RIGHTS_ISSUE Rights Issue 9 : 5 Dividend Detail
06-Jun-2005 13-Jul-2005 29-Jul-2005 DIVIDEND First and Final Dividend RM 0.125 Dividend Detail
05-Jun-2006 14-Jul-2006 01-Aug-2006 DIVIDEND First and Final Dividend RM 0.035 Dividend Detail
29-Nov-2006 15-Dec-2006 29-Dec-2006 DIVIDEND Interim Dividend RM 0.122 Dividend Detail
05-Jun-2007 16-Jul-2007 01-Aug-2007 DIVIDEND Final Dividend RM 0.0906 Dividend Detail
02-Jun-2008 16-Jul-2008 01-Aug-2008 DIVIDEND First and Final Dividend RM 0.02 Dividend Detail
01-Jun-2009 15-Jul-2009 03-Aug-2009 DIVIDEND First and Final Dividend RM 0.02 Dividend Detail
01-Jun-2010 14-Jul-2010 03-Aug-2010 DIVIDEND First and Final Dividend RM 0.02 Dividend Detail
24-Jun-2010 06-Jul-2010 08-Jul-2010 RIGHTS_ISSUE Rights Issue 125 : 100 Dividend Detail
31-May-2011 13-Jul-2011 08-Aug-2011 DIVIDEND First and Final Dividend RM 0.035 Dividend Detail
04-Jun-2012 12-Jul-2012 08-Aug-2012 DIVIDEND First and Final Dividend RM 0.0525 Dividend Detail
29-May-2013 11-Jul-2013 06-Aug-2013 DIVIDEND First and Final Dividend RM 0.065 Dividend Detail
10-Jul-2014 11-Jul-2014 06-Aug-2014 DIVIDEND First and Final Dividend RM 0.025 Dividend Detail
30-Dec-2014 13-Jan-2015 30-Jan-2015 DIVIDEND Interim Dividend RM 0.05 Dividend Detail
25-Apr-2016 27-May-2016 15-Jun-2016 DIVIDEND First and Final Dividend RM 0.0650 Dividend Detail
16-Jan-2017 31-Jan-2017 21-Feb-2017 DIVIDEND Interim Dividend RM 0.09 Dividend Detail
10-Jan-2018 24-Jan-2018 14-Feb-2018 DIVIDEND Interim Dividend RM 0.12 Dividend Detail
03-Jan-2019 23-Jan-2019 15-Feb-2019 DIVIDEND Interim Dividend RM 0.4 Dividend Detail
10-Jan-2020 24-Jan-2020 14-Feb-2020 DIVIDEND Special Dividend RM 0.1400 Dividend Detail
10-Jan-2020 24-Jan-2020 14-Feb-2020 DIVIDEND Interim Dividend RM 0.5100 Dividend Detail
08-Jan-2021 25-Jan-2021 18-Feb-2021 DIVIDEND Interim Dividend RM 0.5800 Dividend Detail
12-Jan-2022 27-Jan-2022 18-Feb-2022 DIVIDEND Interim Dividend RM 0.6300 Dividend Detail
28-Jun-2022 18-Jul-2022 05-Aug-2022 DIVIDEND Interim Dividend RM 0.1600 Dividend Detail
Trade this stock for as low as 0.05% brokerage. Find out more.

  7 people like this.
observatory According to 1Q22 presentation,
Group Operating Revenue +6.3%
Group Gross Written Premium +9.5%
Group core profit before tax RM184.8m (versus RM130.7m in 3M21)

Both GI and life have recorded increases.

While the numbers look good, there are areas of concern in Life business.
New business value was RM59.1 million, decreased by 28.5%
This was mainly due to lower sales from agency, where agency ANP has decreased by 26.9%.

While current year profit has increased, it's the growth in NBV that will deliver the growth of future profits for life.

Is the decline in agency sales a temporary setback?

What is your view on the results?

20/05/2022 11:13 PM
unicornbird obs, do you have friends in insurance industry to check on? sometimes competitor launch promo, which will eat up Allianz new sales.
21/05/2022 3:04 PM
observatory It's an industry wide decline. In fact, according to the presentation, "Market share 3M 2022 increased to 9.3% (3M 2021: 8.8%)."

I'm not sure why the industry is not doing well despite face to face meetings are returning to normal.
21/05/2022 6:03 PM
wsb_investor Q1 always a slow period for insurance sales, with exception of Q1 2021 due to 2020 lockdown.
21/05/2022 8:02 PM
observatory @wsb_investor, thanks for the explanation.

By the way did you read last week weekend edition of The Edge? There was an article about Great Eastern. According to Bloomberg data it quoted, currently market prices this leading life insurer at only 0.53 times price to EV. Price to book is slightly below 1x.

Do other life insurers in this region also suffer from low valuation? What might be the reason?
21/05/2022 8:29 PM
unicornbird wsb, could you please share why Q1 is low sales? is it because agents are on holiday mood, so cannot perform after Xmas holiday
22/05/2022 1:41 PM
wsb_investor Q4 always come with great promotion for all insurers to hit their kpi + Q1 is also Cny period.
22/05/2022 10:23 PM
unicornbird thanks wsb for sharing the good info
23/05/2022 9:09 AM
meowmiao why Allianz good results but price stays? wondering why... and good dividend too
27/05/2022 7:11 PM
PunTatBerSiul Post removed. Why?
31/05/2022 9:18 AM
patrico8 Interim dividend so good.
28/06/2022 8:03 PM
wsb_investor The new CFO is an actuary with very strong technical skill and involved in IFRS17 previously. Impressive and surprised why this angmo suddenly relocating to KL.
04/07/2022 1:04 AM
observatory @wsb_investor, thanks for sharing . The top posts at Allianz Malaysia have undergone rotation recently, typical of MNCs. What's your view on the new leadership under Zakri, Sean and Charles?
04/07/2022 11:24 PM
wsb_investor Not interested on Sean, but the CFO lineup is really interesting. Did some checks, and apparently right now, GE, AIA, Prudential, Allianz and HLA, all CFO are qualified actuaries. The ex Allianz CFO (now Allianz Life CEO) is just a rather normal accountant.
05/07/2022 9:17 AM
observatory Does it really make a difference in the business? Wouldn't an accountant who has been working in the insurance sector for many years would have picked up sufficient actuarial knowledge?
05/07/2022 10:07 AM
wsb_investor There are many ways to present results nicely under IFRS17 due to the principle based nature. There are also ways to design products, that is beneficial under IFRS17. Of course it won't be the CFO that do these ground works, but a CFO that can really understand, will always lean towards a better, actuarial sound decision.
05/07/2022 11:52 AM
observatory What do you mean by product design that is beneficial under IFRS17?
By benefit do you mean greater recognition of profits in the earlier years, but at the expense of lesser profit recognition in the later years? That is more like a matter of presentation.
Any example?
05/07/2022 1:14 PM
wsb_investor There are products that might appear to be loss making under IFRS17 reporting (risk neutral basis), but profitable under real world basis. For example NPAR endowment, Participating products (or in general, saving products).

Certain products will also have high profit recognition in earlier years, despite negative net cashflows, for example investment linked products. There are also products with slow profit recognition, but high positive net cashflows, e.g. MRTA.

It is obviously not easy to maintain a good mix (even pre IFRS17), and to meet distributors' requirements, market competitiveness etc. It is just going to get harder and more complex.
05/07/2022 5:28 PM
observatory Am I right that from shareholders stand point, whether profits are recognized in early or later years does not change the overall profitability? The only challenge is year to year reported profit could be more volatile and obscure, making it difficult if shareholders who value the shares based on reported profit (since Allianz doesn't disclose its EV)

In what way are distributors affected? Isn't profit recognition concern only Allianz and its shareholders, and maybe the tax authorities? Do you mean the distributors are incentivized based on the Allianz's reported annual profit, such that distributors' incentives could be affected if profit recognitions are pushed out to the later years?
06/07/2022 1:12 AM
wsb_investor In general IFRS17 will make profit emerging more stable and less volatile, but there might be exceptional case on certain product type. Yes, profit over the lifetime will be the same, just timing.

Distributors depend on the commission for living, so say if Allianz stop selling less profitable saving product (despite lower comm%, but bigger premium size, and higher absolute commission), agents will not happy. There are a couple of time where agents in Malaysia protested against the insurance companies due to commission related issue. In some extreme cases, some CEOs stepped down due to this.
06/07/2022 12:03 PM
observatory I see. There seems to be a lot more considerations than profit alone when insurance companies push their products.

After reading you comment, I checked out the ISM yearbook for new policies issued in 2021. I found Allianz underwrote a lot of endowment policies than whole life policies. However the market leader Great Eastern has slightly more whole life than endowment. Is there a reason for their different emphasis?

The other point is, as you've mentioned in the past, Allianz sells a lot of investment-linked products which offers better margin. This seems to be a common industry practice. For the entire industry, the premium for new ILP was RM6.6 billion versus RM2.2 billion for traditional products.

In fact companies like AIA, Prudential and even Etiqa sold a much higher proportion of ILP. What is holding Allianz back from selling even more high margin ILPs like its peers? Does it have to do with agent commission factor too?
07/07/2022 12:49 AM
wsb_investor Dont think the classification of whole life/endowment is very straight forward. ILP can be both, and for Allianz, its product strategy previously was to design ILP that only last until age 70 (hence lower price), vs other competitors that design ILP that can last until age 100. Of course right now, regulation changed again and product strategy is slightly different. You can see from ISM yearbook, page 99, AIA ILP almost all classified as whole life, while Allianz ILP almost all classified as endowment.

Not sure where you see Etiqa sold higher proportion of ILP than Allianz. My impression is that Allianz has the highest proportion of ILP (within its inforce policies) among all insurers in Malaysia. Other insurers due to legacy issue, has a big block of traditional business (within inforce business), especially GE and AIA, despite trying to sell more ILP now.
07/07/2022 10:04 PM
observatory Yeah you're right. Almost all of AIA ILP is classified under whole life, whereas Allianz is under endowment. With your explanation it makes sense now.

When I mentioned Etiqa Life has a high proportion of ILP, I refer to page 98-99 (section on new policies issued - individual). I focus only on new policies issued in 2021.
Under the sub-heading of total (for current year), under the Investment-Linked column, total premium = RM175,844,735 (single premiums) + RM520,438,603 (annual premiums) = RM696,283,338.
Under the Ordinary Life column (I suppose ordinary life means traditional products, right?), total premium = RM9,146,117 (single premium) + RM82,263,788 = RM91,409,905.
This is how I've arrived at the conclusion that Etiqa also sells a very high proportion of new ILP policies (RM696 million premium) as opposed to traditional policies (just RM91m premium)

I also check the section "Policies In Force at End of Year - Individual" under page 122-123.
For Allianz Life, the annual premium under "Ordinary Life" is RM1,528,13,953, versus RM2,070,966,065 under "Investment-Linked". Yes, the proportion of Allianz ILP (within in force policies) is higher, but not very much higher.
On the other hand, take Prudential for example. Annual premium under "Ordinary Life" is RM2,746,671,221. Under "Investment-Linked" is RM7,515,202,224. Prudential ILP (within in force policies) is almost triple the size of its ordinary life!
Even HLA ILP is more than double the size of its ordinary life.
It seems that the high proportion ILP is quite common across insurers, where some have a lot higher concentration of ILP.
Have I interpreted the data correctly?
07/07/2022 11:13 PM
wsb_investor Yes you are right. Not sure how those data are being compiled.

Some in force block, you might have products that stop paying premium, especially saving products. Hence can't just look at annual premium. Furthermore saving products with bigger premium size but much lower margin whereas traditional protection products with lower premium size but much higher margin. E.g. HLA is well known for selling saving plans. Its ordinary life maybe is 33% of total, but probably generate less than 10% or even 5% of total profit.
12/07/2022 3:12 PM
observatory Talking about margin, based on Allianz Malaysia analyst presentation, the 2021 NBV margin was 40% (NBV 275.2m divided by ANP 687.2m)
How does it compare to the industry standard? I'm not sure where to get such info.

But I managed to get AIA data. Refer page 49. VONB margin in Malaysia was 57% in 2021, and was even higher at 60% in 2020. Why do AIA products enjoy a far higher margin than Allianz?

13/07/2022 6:04 PM
wsb_investor AIA uses TEV basis (more aggressive assumptions), Allianz uses MCEV basis. Also, Allianz prices its ILP to age 70 only, to get bigger market share, so lower premium and lower profit, whereas AIA (at least used to, not sure about now) prices its ILP up to 100.
13/07/2022 11:50 PM
observatory If I understand correctly, it’s is like AIA sells more premium high margin products to a more affluent market, whereas Allianz sells affordable average margin products to the mass market.
An imperfect analogy could be Louis Vuitton versus Coach? One is luxury, and the other affordable luxury.
Both have similar NBV in 2021 (Allianz 275m versus AIA 283m), but Allianz’s NBV growth slightly outpace AIA over a 3-year period, although AIA grew faster in 2021 (at 26% versus Allianz 15%)
14/07/2022 12:48 PM
wsb_investor AIA 283m is in USD.
14/07/2022 1:16 PM
observatory Yeah, overlooked. So AIA Malaysia NBV is 4 to 5 times of Allianz, and still growing fast, quite amazing.
14/07/2022 2:53 PM
observatory After Affin's AmGeneral Insurance merges with Liberty Insurance, the combined entity will overtake Allianz General to become the largest motor insurer in Malaysia. Do you forsee a lot more competition on the general insurance side?
Some years back the industry combined ratio was above 100%. With the ongoing market liberalization, could GI become loss making again, at least in underwriting losses?
14/07/2022 2:57 PM
wsb_investor Not very familiar with GI business, but AmG/Liberty or AXA/Generali, only AXA is slightly reputable due to online presence, the rest are more or less like local company (Liberty = ex-Uniasia, Generali = ex-MPHB/Magnum) instead of real MNC. Combined entity should have cost saving advantage, but that will take years to materialize. Not foreseeing more competition due to lack of awareness of both Liberty & Generali branding in Malaysia. I aslo don't think UW loss will ever happen again.
14/07/2022 6:17 PM
observatory As shown in page 70-71 of the Yearbook, some of the GIs' combined ratios are quite close to 100%. Axa Affin General, which should have scale, is 99.82% (98.71% in 2020).
The best performer is Loanpac under LPI, where combined ratio is 60% (65% in 2020). I suppose it's helped by its dominance in fire insurance, where industry net claim ratio is only 41%, much lower than motor's 55%.
Fire net claim ratio is only 13% for Loanpac! Whereas Allianz General is as high as 70%.
Net commission ratio, Loanpac is 6%, versus Allianz General 15%.
Any idea why the huge discrepancy in performance?
No wonder LPI share price commands a premium despite limited growth prospect in the sector.
16/07/2022 12:34 PM
wsb_investor https://www.theedgemarkets.com/article/malaysia-said-set-2023-cutoff-foreign-insurer-stake-sales
18/07/2022 1:54 PM
observatory What are the implications?
19/07/2022 1:22 PM
wsb_investor The Group do not provide forecast/estimates for financial results. It is observed that retained earnings would be higher under MRFS 17 as compared to the current MFRS 4 mainly contributed by faster profit emergence for investment-linked products, and deferral of acquisition cost. https://www.allianz.com.my/content/dam/onemarketing/azmb/wwwallianzcommy/pdf/investor-updates/2022/ANNEXURE_2_48TH_AGM_QA.pdf
19/07/2022 6:57 PM
wsb_investor Embedded Value for Allianz Life as at 31 December 2021 was at the range of RM3.5 billion. Embedded value is calculated based on the best estimate assumptions (i.e mortality, persistency, morbidity etc) discounted at risk free rate. https://www.allianz.com.my/content/dam/onemarketing/azmb/wwwallianzcommy/pdf/investor-updates/2022/OTHER_48TH_AGM_QA.pdf
19/07/2022 7:01 PM
wsb_investor AIA/Prudential/Tokio Marine/Zurich might force to IPO/local JV/donation. For some reasons, donation is very unlikely. Regardless if IPO or local JV, there will be public disclosure of price/EV of the transaction (it will be more than 100% for MY market). Hope by then public can notice how deeply undervalue Allianz is.
19/07/2022 7:05 PM
observatory RM3.5b EV is quite close to RHB's and Am Bank's estimate of RM3.3b.

I don't understand when the minutes say discounted at "risk free rate". Does it mean the future profits are discounted at 10 year MGS, which is about 4%, rather than a higher rate?

If discounted at 4%, the EV will be inflated. As a contrast, in page 69 of the AIA presentation I mentioned earlier, AIA adopted a 8.56% discount rate for Malaysia (4% 10Y gov bonds + 4.56% risk premium).
19/07/2022 8:13 PM
observatory Based on what I can find, quite a few public listed life insurers in this region, with the exception of AIA, are priced below their EV!

They are not confined to Chinese insurers such as China Life or Ping An, where valuations are depressed. Take for example, The Edge Saturday edition on May 14 had a table extracted from Bloomberg showing Great Eastern and Prudential were sold at 0.53X and 0.88X P/EV respectively.

Why does the market place a huge discount on life insurers? And not just in Malaysia. Have I missed something?
19/07/2022 8:20 PM
wsb_investor If you only looking at ILP, then yes is discounted with risk free rate, but if you looking at conventional products, at the second half of the policy term, outgo will > income, using risk free discount rate, it is actually more conservative. Another point to add is, for ILP, Allianz also project the fund return with risk free rate, whereas AIA (using TEV basis) project the fund return with high return (much higher than 8.56%). Overall, Allianz's MCEV basis is more conversative, not aggressive.

There are reason why GE and Pru appear to be cheap. For Pru, there are a couple reasons:
1. The EEV tripled in past 3 years (Asia business), but share price didn't catch up
2. There are many corporate activities recently, e.g. spinoff US/UK business, the investor base might change.
3. IFRS profit is on downwards trend for Pru. This shouldn't be a concern due to the flaw of existing IFRS, but again most investors with limited knowledge and only look at IFRS profit.
20/07/2022 1:45 AM
observatory I see. It's quite counter intuitive. Normally when applying a low discount rate to future cash flows will result in a higher valuation. It seems that a lot of industry specific knowledge is required to get a handle on life insurers' valuation.
21/07/2022 12:58 AM
observatory Back to the topic of foreign insurers being forced to dispose 30% stake/ donation. Let's explore a bit.

You mentioned AIA/Prudential/Tokio Marine/Zurich. Assume their combined size in Malaysia is double of Allianz. Currently Allianz's market cap is ~RM4.5b (inclusive of ICPS). At a similar valuation, these four foreign insurers' Malaysian business equity value should be around RM10b.

If they are to be valued at say 50% higher, a 30% stake will worth around RM10b * 1.5 * 30% = RM4b to RM5b range. Not a small sum under current market condition, but still doable. For comparison, the twenty odd Bursa IPOs in 2021 including CTOS raised a total of RM2+ billion.

Who could be the buyers? Local banks like Affin and Am Bank have trimmed their insurance arms. Not sure if larger banks, especially the bancassurance partners of these foreign insurers will be willing to pay premium to acquire stakes.

I suppose GLIC like EPF, KWAP, Khazanah have the capacity to take a slice or even as sole partner. But again are they willing to pay premium?

The negotiation over valuation will not be easy. Don't see why these local investors would like to pay premium for insurers given the competitive market, especially listed insurers are currently priced below EVs. On the other hand, the foreign insurers could not justify to their shareholders if they sell on the cheap. Perhaps that was the reason that Great Eastern donated RM2billion?
21/07/2022 1:05 AM
wsb_investor GE donated the 2bil in a smart way, that's why you don't see a P/L impact of -2bil for GE, and why they opt for this donation. However, the same way is not possible for AIA and Pru. There is no way they will just donate anything. JV is more likely than IPO. Previously in 2018, Pru was exploring JV with KWAP. In term of big GLC, we still got KWSP and PNB. Khazanah already own Sunlife, not sure if will still keen to have a bigger stake.

AIA and Pru are more well established and have been constantly paying dividend, IPO is still OK option. Tokio Marine is much smaller size, and Zurich is still loss making, which make it hardest to fulfill the new regulation.
21/07/2022 9:47 AM
observatory Why did you say GE donated in a smart way? Why can't other insurers copy its way?
If the issue remains unresolved in time, what are the likely action by BNM? Stop them from underwriting new policies?
21/07/2022 8:12 PM
wsb_investor In 2011, ING Malaysia, with TEV of 952mil USD, VNB of 48mil USD, sold to AIA at 1.73bil USD. Allianz Life now with MCEV of 3.5bil MYR, VNB 275mil MYR, but Allianz market cap (with GI) = 4.47 bil MYR.
23/07/2022 10:26 PM
observatory True. We've discussed this point before. However, usually the full valuation can only be realized during M&A, where the buyers are willing to pay the full value for controlling stake. At normal times rational minority investors like EPF, who has no control over the company, are right to demand a discount as their margin of safety.
Similar behavior can be observed in other companies too, for example YTL Power. Based on the recent M&A case in the UK market, the full valuation of its UK asset alone is already a few times over its current market cap. Yet I believe the market is also rational to value the company based only on its dividend yield rather than more elusive asset valuation.
Personally, as a patient investor here, knowing the EV, NBV growth etc gives me peace of mind on the downside protection, while hoping for dividend to grow in the future. When that happens share price should follow. But it probably takes time.
24/07/2022 11:31 AM
observatory Annual reports showed that in 2013 the market cap reached RM4.2b. But PBT and shareholders' fund then were only half of today's.

I noted GWP growth hit 19.9% in 2013, before slowing to about 3% in 2015-17. Last year growth was 7.2%. Maybe the slower growth has made the stock less appealing to the market.
27/07/2022 11:50 PM
observatory LPI has just released Q2 results. Its motor net claims incurred ratio for 2Q22 is 88.8%, as compared to just 60.8% in 2Q21, and 76.3% in 1Q22. The ratio is around low 70% before the pandemic.

According to its press release, "The increase was due to a higher frequency of motor claims reported as most vehicles were back on the road, and due to the increase in average third party bodily injury claims reserve as a result of an increasing trend in court awards."

I wonder if the factor of court catching up with backlog will also show up in Allianz General claim ratio in Q2.
02/08/2022 6:56 PM
observatory "A landmark ruling by the Federal Court has held that victims of road accidents should be automatically compensated by insurance companies without requiring legal action to do so.
According to the report, of the eight appeals, five involved Pacific & Orient Insurance, Amgeneral Insurance, Allianz General Insurance Company, and Malaysian Motor Insurance Pool. The three-person bench, comprised of Rahman as well as Hasnah Mohammed Hashim and Rhodzariah Bujang, awarded RM150,000 in costs to each of the successful parties in the appeal.

The appeals came about as the insurance companies had obtained a declaration in the High Court to nullify the policies of motorists due to allegations of misconduct on the part of the vehicle owners, the FMT report said. This action had denied accident victims monetary compensation that had been due to them, prompting the appeals.
The appeals included a sambung bayar case, where the dispute arose when the vehicle owner attempted to claim on his vehicle following an accident.

However, he had “sold” his vehicle to a third party through such an arrangement, with the insurance company being unaware of this. When it learnt about this, it then obtained a declaration from the High Court to nullify the policy of the motorist, citing misconduct on the part of the vehicle owner. Following this, the insurer refused to cover the vehicle owner’s loss.

In another case, while the Sessions Court had found the driver of the other vehicle negligent after a full trial, the insurance company took a court order alleging it had been defrauded, and declined to pay the vehicle owner who was claiming for damages.

The case victim was eventually found to merely hold a paper judgement, which the Federal Court said was “not even worth the paper it was written on,” continuing that it was unfair because the victim’s constitutional rights to be treated fairly had been infringed"


10/08/2022 12:16 PM
observatory With this ruling, motor insurance companies will automatically pick up the bill. It's only right that innocent accident victims should not go through the legal nightmare just because the motorists are at fault and insurance companies refuse to pay. But could there be unintended consequences?

With the ongoing liberalization, insurance companies need to better differentiate pricing based on motorists' past records, such as traffic summons.
10/08/2022 12:28 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program

381  350  543  1001 

Top 10 Active Counters
 MTRONIC 0.050.00 
 HARTA 1.74-0.03 
 PHB 0.015+0.01 
 TWL 0.055-0.005 
 G3 0.030.00 
 TOPGLOV 0.86+0.025 
 MYEG 0.8050.00 
 CSH 0.045-0.005 
 INFOTEC 0.37-0.035 
 HARTA-C99 0.04-0.11